Slade Health

Slade Health is an Australian healthcare services company focused on sterile compounding, hospital pharmacy support, and clinical trial services rather than novel drug discovery. The company supplies compounded chemotherapy, antibiotics, analgesics, theatre lines, and total parenteral nutrition products to more than 200 hospital partners across Australia and New Zealand. Slade Health operates TGA-licensed compounding facilities and supports Phase 1-4 clinical trials, primarily in oncology and haematology. It is part of Icon Group and functions as the group’s pharmacy and compounding arm in Australia and New Zealand. For a biotech analyst, Slade Health is best understood as a commercial specialty compounding and hospital pharmacy platform with strong oncology infrastructure, not a traditional therapeutics developer.